XML 74 R63.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidating Financial Information - Cash Flows (Details) - USD ($)
$ in Thousands
1 Months Ended 9 Months Ended
Oct. 02, 2018
Jul. 03, 2018
Apr. 03, 2018
Jun. 30, 2018
Sep. 30, 2018
Sep. 30, 2017
Condensed Consolidating Statements Of Cash Flows            
Net cash provided by (used for) operating activities         $ 76,919 $ (36,109)
Cash flows from investing activities:            
Purchases of investments         (676) (6,722)
Sales and maturities of investments         2,962 12,533
Cash paid for acquisitions of businesses, net of cash acquired           (50,764)
Capital expenditures         (338,968) (448,864)
Proceeds from sales of assets and insurance claims         86,666 32,805
Net cash (used for) provided by investing activities         (250,016) (461,012)
Cash flows from financing activities:            
Increase (decrease) in cash overdrafts         (261) (78)
Debt issuance costs         (13,262) (11,039)
Proceeds from (payments for) issuance of common shares       $ 21,800 301,835 8,300
Reduction of long-term debt         (774,802) (382,815)
Dividends to shareholders $ (21,400) $ (21,500) $ (19,100)   (57,661) (51,346)
Proceeds from (payments for) commercial paper, net         (40,000) 78,000
Purchase of capped call hedge transactions           (40,250)
Proceeds from revolving credit facilities         905,000 410,000
Reduction in revolving credit facilities         (1,200,000)  
Dividends to preferred shareholders         (3,680)  
Proceeds from (payments for) short-term borrowings         252 (528)
Proceeds from issuance of preferred stock, net of issuance costs         278,358  
Proceeds from issuance of long-term debt         800,000 411,200
Payments on term loan           (162,500)
Cash proceeds (payments) from equity component of exchangeable debt           159,952
Noncontrolling interest contribution           20,000
Distributions to noncontrolling interest         (4,676) (7,272)
Other changes         (3,722) (7,864)
Net cash (used for) provided by financing activities         187,381 423,760
Effect of exchange rate changes on cash and cash equivalents         (5,320) 251
Net increase (decrease) in cash and cash equivalents         8,964 (73,110)
Cash and cash equivalents and restricted cash, beginning of period         342,029 264,990
Cash and cash equivalents and restricted cash, end of period         350,993 191,880
Consolidating Adjustments            
Condensed Consolidating Statements Of Cash Flows            
Net cash provided by (used for) operating activities         (40,017) (88,939)
Cash flows from investing activities:            
Cash paid for investments in consolidated affiliates         786,500 76,060
Net cash (used for) provided by investing activities         786,500 76,060
Cash flows from financing activities:            
Dividends to shareholders         9,317 8,939
Proceeds from parent contributions         (786,500) (76,060)
Distribution from subsidiary to parent         30,700 80,000
Net cash (used for) provided by financing activities         (746,483) 12,879
Parent Company | Reportable Legal Entities            
Condensed Consolidating Statements Of Cash Flows            
Net cash provided by (used for) operating activities         82,365 103,187
Cash flows from investing activities:            
Cash paid for investments in consolidated affiliates         (587,500) (100)
Net cash (used for) provided by investing activities         (587,500) (100)
Cash flows from financing activities:            
Proceeds from (payments for) issuance of common shares         301,835 8,300
Dividends to shareholders         (66,978) (60,285)
Proceeds from issuance of intercompany debt         20,000 35,000
Dividends to preferred shareholders         (3,680)  
Proceeds from issuance of preferred stock, net of issuance costs         278,358  
Paydown of intercompany debt         (21,000) (79,000)
Other changes         (3,722) (7,864)
Net cash (used for) provided by financing activities         504,813 (103,849)
Net increase (decrease) in cash and cash equivalents         (322) (762)
Cash and cash equivalents and restricted cash, beginning of period         1,091 1,148
Cash and cash equivalents and restricted cash, end of period         769 386
Guarantor Subsidiaries | Reportable Legal Entities            
Condensed Consolidating Statements Of Cash Flows            
Net cash provided by (used for) operating activities         (203,493) (199,071)
Cash flows from investing activities:            
Change in intercompany balances         327,555 (424,133)
Net cash (used for) provided by investing activities         327,555 (424,133)
Cash flows from financing activities:            
Debt issuance costs         (13,262) (11,039)
Reduction of long-term debt         (774,802) (270,269)
Proceeds from (payments for) commercial paper, net         (40,000) 78,000
Proceeds from issuance of intercompany debt           20,000
Purchase of capped call hedge transactions           (40,250)
Proceeds from revolving credit facilities         905,000 410,000
Reduction in revolving credit facilities         (1,200,000)  
Proceeds from issuance of long-term debt         800,000 411,200
Payments on term loan           (162,500)
Paydown of intercompany debt           (20,000)
Cash proceeds (payments) from equity component of exchangeable debt           159,952
Proceeds from parent contributions         199,000 37,980
Net cash (used for) provided by financing activities         (124,064) 613,074
Net increase (decrease) in cash and cash equivalents         (2) (10,130)
Cash and cash equivalents and restricted cash, beginning of period         44 10,177
Cash and cash equivalents and restricted cash, end of period         42 47
Other Subsidiaries (Non-Guarantors) | Reportable Legal Entities            
Condensed Consolidating Statements Of Cash Flows            
Net cash provided by (used for) operating activities         238,064 148,714
Cash flows from investing activities:            
Purchases of investments         (676) (6,722)
Sales and maturities of investments         2,962 12,533
Cash paid for acquisitions of businesses, net of cash acquired           (50,764)
Cash paid for investments in consolidated affiliates         (199,000) (75,960)
Capital expenditures         (338,968) (448,864)
Proceeds from sales of assets and insurance claims         86,666 32,805
Change in intercompany balances         (327,555) 424,133
Net cash (used for) provided by investing activities         (776,571) (112,839)
Cash flows from financing activities:            
Increase (decrease) in cash overdrafts         (261) (78)
Reduction of long-term debt           (112,546)
Proceeds from issuance of intercompany debt         (20,000) (55,000)
Proceeds from (payments for) short-term borrowings         252 (528)
Paydown of intercompany debt         21,000 99,000
Noncontrolling interest contribution           20,000
Distributions to noncontrolling interest         (4,676) (7,272)
Proceeds from parent contributions         587,500 38,080
Distribution from subsidiary to parent         (30,700) (80,000)
Net cash (used for) provided by financing activities         553,115 (98,344)
Effect of exchange rate changes on cash and cash equivalents         (5,320) 251
Net increase (decrease) in cash and cash equivalents         9,288 (62,218)
Cash and cash equivalents and restricted cash, beginning of period         340,894 253,665
Cash and cash equivalents and restricted cash, end of period         $ 350,182 $ 191,447